Login / Signup
The dilemma of whether to continue TNFα blocker therapy in an ulcerative colitis patient newly diagnosed with a malignant melanoma and melanoma in situ.
Louise Zuzarte
Sara Mirhadi
Richard A Carr
Simon Tso
Published in:
BMJ case reports (2019)
Keyphrases
</>
newly diagnosed
ulcerative colitis
rheumatoid arthritis
case report
angiotensin converting enzyme
stem cells
mesenchymal stem cells
cell therapy
angiotensin ii
basal cell carcinoma